| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 59.3277 | 64 |
| GSM780708 | Untreated after 4 days (C2_1) | 58.9071 | 64 |
| GSM780709 | Untreated after 4 days (C3_1) | 61.067 | 65 |
| GSM780719 | Untreated after 4 days (C1_2) | 60.8628 | 65 |
| GSM780720 | Untreated after 4 days (C2_2) | 63.0368 | 66 |
| GSM780721 | Untreated after 4 days (C3_2) | 58.1982 | 63 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 65.2304 | 67 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 59.0116 | 64 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 63.9034 | 67 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 58.8382 | 64 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 76.8914 | 71 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 62.7337 | 66 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 63.3015 | 66 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 64.379 | 67 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 65.3664 | 67 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 64.3053 | 67 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 66.7516 | 68 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 60.9855 | 65 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 66.9615 | 68 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 68.1982 | 68 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 68.9376 | 69 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 52.2411 | 55 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 64.5232 | 67 |